变种对被动直立倾斜的反应.

Efficacy and Safety of Ambroxol Lozenges in the Treatment of Acute Uncomplicated Sore Throat - a Pooled Analysis.

Drug research·2016

Efficacy and Safety of an Oral Ambroxol Spray in the Treatment of Acute Uncomplicated Sore Throat.

Drug research·2015

A multi-centre, randomised, double-blind, placebo-controlled clinical trial on the efficacy and tolerability of GeloMyrtol® forte in acute bronchitis.

Drug research·2013

Bioequivalence of a novel minitablet formulation of levetiracetam.

Arzneimittel-Forschung·2012

Nanotechnologic biosensor ellipsometry and biomarker pattern analysis in the evaluation of atherosclerotic risk profile.

Biosensors & bioelectronics·2008

Erythromycin increases plasma concentrations of alpha-dihydroergocryptine in humans.

Clinical pharmacology and therapeutics·2001

1-month versus 12-month dual antithrombotic therapy after percutaneous coronary intervention in patients with atrial fibrillation (OPTIMA-AF): a multicentre, open-label, hybrid non-inferiority and superiority, randomised, controlled trial.

Lancet (London, England)·2026

Multidomain lifestyle intervention for the prevention of cognitive decline in at-risk older adults in Latin America (LatAm-FINGERS): a single-blind, multicentre, randomised controlled trial.

Lancet (London, England)·2026

Advancing the relevance of clinical trials for older patients.

Lancet (London, England)·2026

Temocillin versus carbapenems for bacteraemia due to third-generation cephalosporin-resistant Enterobacterales in Spain (ASTARTÉ): a multicentre, phase 3, open-label, non-inferiority, randomised clinical trial.

Lancet (London, England)·2026

Fixed-duration pirtobrutinib plus venetoclax-rituximab versus venetoclax-rituximab for patients with previously treated chronic lymphocytic leukaemia or small lymphocytic lymphoma (BRUIN CLL-322): an open-label, multicentre, randomised, controlled, phase 3 trial.

Lancet (London, England)·2026

Children in all policies: lessons from a global collaboration to promote the health and wellbeing of children and future generations.

Lancet (London, England)·2026

Plasma-induced chemical and structural activation of 2D nanomaterial coatings for antibacterial surfaces.

Nanoscale·2026

Current-Generation Crosslinked Polyethylenes for Total Hip Arthroplasty: Mechanistic Insights Into Oxidative Stability and Antioxidant Efficiency.

Journal of biomedical materials research. Part B, Applied biomaterials·2026

Lab-on-a-chip-compatible graphene oxide coatings via SAW atomization for supporting cell proliferation.

In vitro models·2026

The DD11 Material Components and Properties Impact and Relationship on Cutting Force in Progressive Stamping.

Materials (Basel, Switzerland)·2026

MXenes for Defense-Oriented Multifunctional Systems: From Synthesis and Property Regulation to Deployment Challenges.

Materials (Basel, Switzerland)·2026

Aging Trajectory Analysis of Asphalt: Differential Regulation of UV Aging Processes by Anti-Aging Agents with Varied Mechanisms.

Materials (Basel, Switzerland)·2026

相关实验视频

变种对被动直立倾斜的反应.

相关概念视频

Efficacy and Safety of Ambroxol Lozenges in the Treatment of Acute Uncomplicated Sore Throat - a Pooled Analysis.

Efficacy and Safety of an Oral Ambroxol Spray in the Treatment of Acute Uncomplicated Sore Throat.

A multi-centre, randomised, double-blind, placebo-controlled clinical trial on the efficacy and tolerability of GeloMyrtol® forte in acute bronchitis.

Bioequivalence of a novel minitablet formulation of levetiracetam.

Nanotechnologic biosensor ellipsometry and biomarker pattern analysis in the evaluation of atherosclerotic risk profile.

Erythromycin increases plasma concentrations of alpha-dihydroergocryptine in humans.

1-month versus 12-month dual antithrombotic therapy after percutaneous coronary intervention in patients with atrial fibrillation (OPTIMA-AF): a multicentre, open-label, hybrid non-inferiority and superiority, randomised, controlled trial.

Multidomain lifestyle intervention for the prevention of cognitive decline in at-risk older adults in Latin America (LatAm-FINGERS): a single-blind, multicentre, randomised controlled trial.

Advancing the relevance of clinical trials for older patients.

Temocillin versus carbapenems for bacteraemia due to third-generation cephalosporin-resistant Enterobacterales in Spain (ASTARTÉ): a multicentre, phase 3, open-label, non-inferiority, randomised clinical trial.

Fixed-duration pirtobrutinib plus venetoclax-rituximab versus venetoclax-rituximab for patients with previously treated chronic lymphocytic leukaemia or small lymphocytic lymphoma (BRUIN CLL-322): an open-label, multicentre, randomised, controlled, phase 3 trial.

Children in all policies: lessons from a global collaboration to promote the health and wellbeing of children and future generations.

Plasma-induced chemical and structural activation of 2D nanomaterial coatings for antibacterial surfaces.

Current-Generation Crosslinked Polyethylenes for Total Hip Arthroplasty: Mechanistic Insights Into Oxidative Stability and Antioxidant Efficiency.

Lab-on-a-chip-compatible graphene oxide coatings via SAW atomization for supporting cell proliferation.

The DD11 Material Components and Properties Impact and Relationship on Cutting Force in Progressive Stamping.

MXenes for Defense-Oriented Multifunctional Systems: From Synthesis and Property Regulation to Deployment Challenges.

Aging Trajectory Analysis of Asphalt: Differential Regulation of UV Aging Processes by Anti-Aging Agents with Varied Mechanisms.

相关实验视频

变种对被动直立倾斜的反应.

相关概念视频

相关文章